Ocular immune privilege: therapeutic opportunities from an experiment of nature
The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the vitreous space, there are higher chances of exposure to systemic circulation,15 whereas the subretinal space does not expose AAV to systemic circulation, owing to the blood-retina barrier.9,33”
From Systemic and local immune responses to intraocular AAV vector administration in non-human primates (2022) · cites this paper as [9]
In the citing paper
“Idebenone (Raxone), a synthetic analogue of coenzyme Q10, has been used by practitioners in the European Union albeit with controversial efficacy, because results from a phase 3 study were not statistically different from placebo.11”
In the citing paper
“The eye was historically considered to be an immune privileged site, as a result of several features. These include the blood-retinal barrier formed by tight junctions between endothelial and retinal pigmented epithelium cells as well as in retinal vessels, the lack of anatomically defined lymphatic drainage and an intraocular anti-inflammatory and immunomodulatory micro-environment [43].”
From Characterization of anti-AAV2 neutralizing antibody levels in sheep prior to and following intravitreal AAV2.7m8 injection (2024) · cites this paper as [43]
In the citing paper
“Additionally, there are lower risks of immunogenicity when targeting AAV vectors towards relatively immune-privileged sites, such as the subretinal space and the cochlea [93,94].”
From Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders (2022) · cites this paper as [93]
Citations
Cites
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005 · cited 1×
“CD95L, which is expressed constitutively by cells of the eye (and other immune-privileged tissues), is partially responsible for acceptance of orthotopic corneal allografts, and for making the cornea and retinal pigment epithelium immune-privileged tissue”
BackgroundMedawar, P. B. (1948) · PubMed · Cited by 1,109
Immunologically Privileged Sites
Barker, C. F., & Billingham, R. E. (1978) · Advances in Immunology · doi:10.1016/s0065-2776(08)60930-x · Cited by 815
PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2
Carter, L. L., Fouser, L. A., Jussif, J., Fitz, L., Deng, B., Wood, C. R., Collins, M., Honjo, T., Freeman, G. J., & Carreno, B. M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200203)32:3<634::aid-immu634>3.0.co;2-9 · Cited by 673
Immunobiology of Tissue Transplantation: A Return to the Passenger Leukocyte Concept
Laffery, K. J., Prowse, S. J., Simeonovic, C. J., & Warren, H. S. (1983) · Annual Review of Immunology · doi:10.1146/annurev.iy.01.040183.001043 · Cited by 509
Suda, T., Hashimoto, H., Tanaka, M., Ochi, T., & Nagata, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.2045 · Cited by 508 · cited 1×
“Attempts to achieve this goal with CD95L have already been made and the results are mixe”
ResultIdentification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor.
Cousins, S. W., McCabe, M. M., Danielpour, D., & Streilein, J. W. (1991) · PubMed · Cited by 477
Self-citationKang, S.-M., Schneider, D. B., Lin, Z., Hanahan, D., Dichek, D. A., Stock, P. G., & Baekkeskov, S. (1997) · Nature Medicine · doi:10.1038/nm0797-738 · Cited by 450 · cited 1×
“First, conventional immune-recognition pathways can be interrupted by providing allografts with healthy corneal epithelium, or factors derived from this tissue that suppress lymphangiogenesis and attendant inflammatio”
BackgroundSo, K.-F., & Aguayo, A. J. (1985) · Brain Research · doi:10.1016/0006-8993(85)91047-9 · Cited by 390
CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
Stuart, P. M., Griffith, T. S., Usui, N., Pepose, J., Yu, X., & Ferguson, T. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119173 · Cited by 367 · cited 1×
“CD95L, which is expressed constitutively by cells of the eye (and other immune-privileged tissues), is partially responsible for acceptance of orthotopic corneal allografts, and for making the cornea and retinal pigment epithelium immune-privileged tissue”
BackgroundSonoda, K.-H., Exley, M., Snapper, S., Balk, S. P., & Stein-Streilein, J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.9.1215 · Cited by 354
Indirect presentation of MHC antigens in transplantation
Shoskes, D. A., & Wood, K. J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90023-x · Cited by 346 · cited 1×
“that normally activate direct alloreactive effector T cell”
BackgroundThe Corneal Stroma Is Endowed with a Significant Number of Resident Dendritic Cells
Hamrah, P., Liu, Y., Zhang, Q., & Dana, M. R. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0838 · Cited by 323 · cited 1×
“Compared with rejection of other types of graft, corneal allograft rejection is delayed, in part because the normal cornea lacks MHC class-II-expressing antigen-presenting cells (APCs”
BackgroundSONODA, Y., & STREILEIN, J. W. (1992) · Transplantation · doi:10.1097/00007890-199210000-00026 · Cited by 297
Self-citationStreilein, J. W. (1995) · Science · doi:10.1126/science.270.5239.1158 · Cited by 295
Self-citationApte, R. S., Sinha, D., Mayhew, E., Wistow, G. J., & Niederkorn, J. Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.5693 · Cited by 253
Wilbanks, G. A., Mammolenti, M., & Streilein, J. W. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220125 · Cited by 249 · cited 1×
“Finally, tolerance of the eye-derived type can be created by pre-treating graft recipients with their own conventional APCs that have been converted into ACAID-inducing cells by treatment in vitro with TGF-β (or thrombospondin) and donor alloantigen”
BackgroundSelf-citationCorneal Lymphangiogenesis: Evidence, Mechanisms, and Implications for Corneal Transplant Immunology
Cursiefen, C., Chen, L., Dana, M. R., & Streilein, J. W. (2003) · Cornea · doi:10.1097/00003226-200304000-00021 · Cited by 246
Self-citationHohlbaum, A. M., Moe, S., & Marshak-Rothstein, A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1209 · Cited by 241 · cited 1×
“Attempts to achieve this goal with CD95L have already been made and the results are mixe”
ResultSonoda, K.-H., Faunce, D. E., Taniguchi, M., Exley, M., Balk, S., & Stein-Streilein, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.42 · Cited by 240
Immune Response to Immunization Via the Anterior Chamber of the Eye
Kaplan, H. J., & Streilein, J. W. (1977) · The Journal of Immunology · doi:10.4049/jimmunol.118.3.809 · Cited by 237
Self-citationImmunity causing blindness: five different paths to herpes stromal keratitis
Streilein, J. W., Dana, M. R., & Ksander, B. R. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01114-6 · Cited by 233
Self-citationTaylor, A. W., Streilein, J. W., & Cousins, S. W. (1992) · Current Eye Research · doi:10.3109/02713689208999545 · Cited by 226 · cited 1×
“cgi?l=5443">α-MSH ) in AqH prevents responding T cells from secreting pro-inflammatory cytokines (such as IFN-γ), but has no important effect on proliferatio”
BackgroundSelf-citationCorneal allografts fail to express Ia antigens
Streilein, J. W., Toews, G. B., & Bergstresser, P. R. (1979) · Nature · doi:10.1038/282326a0 · Cited by 222 · cited 1×
“Compared with rejection of other types of graft, corneal allograft rejection is delayed, in part because the normal cornea lacks MHC class-II-expressing antigen-presenting cells (APCs”
BackgroundSelf-citationIndirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo.
Lee, R. S., Grusby, M. J., Glimcher, L. H., Winn, H. J., & Auchincloss, H. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.865 · Cited by 221 · cited 1×
“that normally activate direct alloreactive effector T cell”
BackgroundTGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells.
Takeuchi, M., Alard, P., & Streilein, J. W. (1998) · PubMed · Cited by 220
Self-citationSTEIN-STREILEIN, J., & STREILEIN, J. W. (2002) · International Reviews of Immunology · doi:10.1080/08830180212066 · Cited by 218
Self-citationImmune privilege as the result of local tissue barriers and immunosuppressive microenvironments
Streilein, J. W. (1993) · Current Opinion in Immunology · doi:10.1016/0952-7915(93)90064-y · Cited by 214 · cited 1×
“The biological reasons for immune privilege remained obscure after its discovery, but experimental analyses during the past few decades have produced data that are helping researchers to unravel this myster”
BackgroundSelf-citationLiu, Y., Hamrah, P., Zhang, Q., Taylor, A. W., & Dana, M. R. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20010838 · Cited by 214 · cited 1×
“Third, immature MHC class-II-negative APCs in the graft rapidly undergo maturation and upregulate MHC class II expression as they pass through the inflamed graft be”
BackgroundKaplan, H. J., & Streilein, J. W. (1977) · PubMed · Cited by 208
Self-citationTaylor, A. W., Streilein, J. W., & Cousins, S. W. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.3.1080 · Cited by 204
Self-citationTolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells
Sohn, J.-H., Bora, P. S., Suk, H.-J., Molina, H., Kaplan, H. J., & Bora, N. S. (2003) · Nature Medicine · doi:10.1038/nm814 · Cited by 201
Differential expression of the complement regulatory proteins in the human eye.
Bora, N. S., Gobleman, C. L., Atkinson, J. P., Pepose, J. S., & Kaplan, H. J. (1993) · PubMed · Cited by 186
Subretinal space and vitreous cavity as immunologically privileged sites for retinal allografts.
Jiang, L. Q., Jorquera, M., & Streilein, J. W. (1993) · PubMed · Cited by 182
Self-citationWilbanks, G. A., & Streilein, J. W. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.8.2610 · Cited by 177
Self-citationMIP-2 Recruits NKT Cells to the Spleen During Tolerance Induction
Faunce, D. E., Sonoda, K.-H., & Stein-Streilein, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.313 · Cited by 174 · cited 1×
“cgi?l=2920">CXCL2 ) that, in turn, recruits NKT cells to the sit”
BackgroundStudies on the problem of corneal homografts
Billingham, R. E., & Boswell, T. (1953) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1953.0049 · Cited by 174 · cited 1×
“Medawar's colleague, Rupert Billingham, provided evidence that the cornea of the eye is an immune-privileged tissu”
BackgroundWilbanks, G. A., & Streilein, J. W. (1990) · PubMed · Cited by 172
Self-citationNamba, K., Kitaichi, N., Nishida, T., & Taylor, A. W. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.5.946 · Cited by 164 · cited 1×
“T cells that are activated in the presence of α-MSH or AqH can suppress the activation and effector function of bystander T cell”
BackgroundTGF-β Promotes Immune Deviation by Altering Accessory Signals of Antigen-Presenting Cells
Takeuchi, M., Alard, P., & Streilein, J. W. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1589 · Cited by 161
Self-citationDeviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice.
Niederkorn, J. Y., Streilein, J. W., & Shadduck, J. A. (1981) · PubMed · Cited by 160
Self-citationHe, Y.-G., ROSS, J. R., & Niederkorn, J. Y. (1991) · PubMed · Cited by 151
IL-6 antagonizes TGF-beta and abolishes immune privilege in eyes with endotoxin-induced uveitis.
Ohta, K., Yamagami, S., Taylor, A. W., & Streilein, J. W. (2000) · PubMed · Cited by 147
Self-citationImmune privilege in the anterior chamber of the eye
Niederkorn, J. Y. (2002) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v22.i1.20 · Cited by 147
Namba, K., Kitaichi, N., Nishida, T., & Taylor, A. W. (2002) · PubMed · Cited by 147
Wilbanks, G. A., Mammolenti, M., & Streilein, J. W. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.9.3018 · Cited by 143
Self-citationSohn, J.-H., Kaplan, H. J., Suk, H.-J., Bora, P. S., & Bora, N. S. (2000) · PubMed · Cited by 142
ROLE OF FAS-FAS LIGAND INTERACTIONS IN THE IMMUNOREJECTION OF ALLOGENEIC MOUSE CORNEAL TRANSPLANTS1
Yamagami, S., Kawashima, H., Tsuru, T., Yamagami, H., Kayagaki, N., Yagita∥, H., Okumura, K., & Gregerson, D. S. (1997) · Transplantation · doi:10.1097/00007890-199710270-00004 · Cited by 142 · cited 1×
“CD95L, which is expressed constitutively by cells of the eye (and other immune-privileged tissues), is partially responsible for acceptance of orthotopic corneal allografts, and for making the cornea and retinal pigment epithelium immune-privileged tissue”
BackgroundSonoda, K., & Stein‐Streilein, J. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200203)32:3<848::aid-immu848>3.0.co;2-i · Cited by 137
Analysis of immune deviation elicited by antigens injected into the subretinal space.
Wenkel, H., & Streilein, J. W. (1998) · PubMed · Cited by 136
Self-citationEvidence that retinal pigment epithelium functions as an immune-privileged tissue.
Wenkel, H., & Streilein, J. W. (2000) · PubMed · Cited by 135
Self-citationStreilein, J. W., Niederkorn, J. Y., & Shadduck, J. A. (1980) · The Journal of Experimental Medicine · doi:10.1084/jem.152.4.1121 · Cited by 134 · cited 1×
“Antigenic material that is placed in the anterior chamber elicits a deviant systemic immune response that includes primed CD8 + cytotoxic T cells and the generation of NON-COMPLEMENT-FIXING ANTIBODIES , but excludes CD4 + T helper 1 (T H 1) and T H 2 cells, and B cells that secrete COMPLEMENT-FIXING ANTIBODIES”
BackgroundSelf-citationTaylor, A. W., Yee, D. G., & Streilein, J. W. (1998) · PubMed · Cited by 125
Self-citationFaunce, D. E., & Stein‐Streilein, J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.31 · Cited by 124
Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
Yamada, J., Kurimoto, I., & Streilein, J. (1999) · PubMed · Cited by 119
Self-citationIshida, K., Panjwani, N., Cao, Z., & Streilein, J. W. (2003) · Ocular Immunology and Inflammation · doi:10.1076/ocii.11.2.91.15914 · Cited by 113
Self-citationSano, Y., Ksander, B. R., & Streilein, J. W. (1995) · PubMed · Cited by 112
Self-citationγδ T Cells Are Needed for Ocular Immune Privilege and Corneal Graft Survival
Skelsey, M. E., Mellon, J., & Niederkorn, J. Y. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4327 · Cited by 109
Sheibani, N., Sorenson, C. M., Cornelius, L. A., & Frazier, W. A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1903 · Cited by 109
Niederkorn, J. Y., & Streilein, J. W. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.6.2670 · Cited by 108
Self-citationThe eye’s view of antigen presentation
Streilein, J. W., Masli, S., Takeuchi, M., & Kezuka, T. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00393-2 · Cited by 105 · cited 1×
“Whereas afferent T Reg cells of ACAID act in secondary lymphoid organs, the efferent T Reg cells of ACAID act in the periphery, including the ey”
BackgroundSelf-citationSugita, S., & Streilein, J. W. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030097 · Cited by 101
Self-citationKaplan, H. J., & Streilein, J. W. (1978) · PubMed · Cited by 99
Self-citationD’ORAZIO, & NIEDERKORN (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00581.x · Cited by 99
Wilbanks, G. A., & Streilein, J. W. (1990) · PubMed · Cited by 98
Self-citationInhibition of lymphocyte proliferation by aqueous humor.
Kaiser, C. J., Ksander, B. R., & Jw, S. (1989) · PubMed · Cited by 97
CELL DEATH AND IMMUNE PRIVILEGE
FERGUSON, T. A., GREEN, D. R., & GRIFFITH, T. S. (2002) · International Reviews of Immunology · doi:10.1080/08830180212058 · Cited by 95
Does innate immune privilege exist?
Streilein, J. W., & Stein‐Streilein, J. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.4.479 · Cited by 93
Self-citationT-cell mediated responses in a murine model of orthotopic corneal transplantation.
Joo, C., Pepose, J. S., & Stuart, P. M. (1995) · PubMed · Cited by 91
Ohta, K., Wiggert, B., Yamagami, S., Taylor, A. W., & Streilein, J. W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1185 · Cited by 89
Self-citationProlongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody.
Ayliffe, W., Alam, Y., Bell, E. B., McLeod, D., & Hutchinson, I. V. (1992) · British Journal of Ophthalmology · doi:10.1136/bjo.76.10.602 · Cited by 89 · cited 1×
“cgi?l=920">CD4 + T cells are the primary, if not the exclusive, cellular mediators of acute corneal graft rejectio”
BackgroundGa, W., & Jw, S. (1992) · PubMed · Cited by 87
Hara, Y., Caspi, R. R., Wiggert, B. O., Chan, C., Wilbanks, G. A., & Streilein, J. W. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.6.1685 · Cited by 85
Self-citationMembrane Fas Ligand Activates Innate Immunity and Terminates Ocular Immune Privilege
Gregory, M. S., Repp, A. C., Hohlbaum, A. M., Saff, R. R., Marshak‐Rothstein, A., & Ksander, B. R. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2727 · Cited by 84
Pearlman, E. M., Lass, J. H., Bardenstein, D. S., Köpf, M., Hazlett, F. E., Diaconu, E., & Kazura, J. W. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.4.931 · Cited by 84
HLA ANTIGENS IN OCULAR TISSUES
Abi‐Hanna, D., Wakefield, D., & Watkins, S. (1988) · Transplantation · doi:10.1097/00007890-198803000-00021 · Cited by 83
Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59.
Sohn, J.-H., Kaplan, H. J., Suk, H.-J., Bora, P. S., & Bora, N. S. (2000) · PubMed · Cited by 82
Regional Immunity and Ocular Immune Privilege
Streilein, J. W. (1999) · KARGER eBooks · doi:10.1159/000058741 · Cited by 82
Self-citationIMMUNOLOGY AND IMMUNOMODULATION OF CORNEAL TRANSPLANTATION
Niederkorn, J. Y. (2002) · International Reviews of Immunology · doi:10.1080/08830180212064 · Cited by 80
Novel production of interleukin-1 receptor antagonist peptides in normal human cornea.
Kennedy, M. C., Rosenbaum, J. T., Brown, J., Planck, S. R., Huang, X., Armstrong, C. A., & Ansel, J. C. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117679 · Cited by 79
Immune Privilege and Immunogenicity Reside among Different Layers of the Mouse Cornea
Hori, J., Joyce, N. C., & Streilein, J. W. (2007) · Ocular Immunology and Inflammation · doi:10.1080/09273940701382374 · Cited by 78
Self-citationThe distribution and ontogeny of MHC antigens in murine ocular tissue.
Wang, H. M., Kaplan, H. J., Chan, W., & Johnson, M. (1987) · PubMed · Cited by 75
Hara, Y., Caspi, R. R., Wiggert, B. O., Dorf, M. E., & Streilein, J. W. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.12.4116 · Cited by 75
Self-citationOcular Immune Privilege and the Impact of Intraocular Inflammation
Streilein, J. W., Ohta, K., Mo, J. S., & Taylor, A. W. (2002) · DNA and Cell Biology · doi:10.1089/10445490260099746 · Cited by 74 · cited 1×
“Immune privilege and the immunosuppressive intraocular microenvironment is resilient when challenged with inflammation, infection and traum”
BackgroundSelf-citationD’Orazio, T. J., Mayhew, E., & Niederkorn, J. Y. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.26 · Cited by 73
Somatostatin Is an Immunosuppressive Factor in Aqueous Humor
Taylor, A. W., & Yee, D. G. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1216 · Cited by 73 · cited 1×
“cgi?l=27151">VIP ) and somatastatin account for the ability of normal AqH to suppress antigen- and mitogen-driven T-cell proliferatio”
BackgroundImmune Response to Immunization via the Anterior Chamber of the Eye
Kaplan, H. J., & Streilein, J. W. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.120.3.689 · Cited by 71
Self-citationWang, Y., Goldschneider, I., O’Rourke, J., & Cone, R. E. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.5.741 · Cited by 70 · cited 1×
“Circumstantial evidence indicates that these cells migrate to the spleen where they participate in the induction of the CD4 + and CD8 + T regulators of ACAI”
BackgroundWang, Y., Goldschneider, I., Foss, D., Wu, D., O’Rourke, J., & Cone, R. E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.5.2150 · Cited by 70
Masli, S., Turpie, B., Hecker, K. H., & Streilein, J. W. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2264 · Cited by 65
Self-citationAnalysis of cytotoxic T cell responses to intracameral allogeneic tumors.
Ksander, B. R., & Streilein, J. W. (1989) · PubMed · Cited by 65
Self-citationEpithelium-deficient corneal allografts display immune privilege beneath the kidney capsule.
Hori, J., Joyce, N. C., & Streilein, J. W. (2000) · PubMed · Cited by 64
Self-citationKatagiri, K., Zhang-Hoover, J., Mo, J. S., Stein‐Streilein, J., & Streilein, J. W. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.84 · Cited by 64
Self-citationSano, Y., Ksander, B. R., & Streilein, J. W. (1997) · PubMed · Cited by 62
Self-citationGoslings, W. R. O., Продеус, А. П., Streilein, J. W., Carroll, M. C., Jager, M. J., & Taylor, A. W. (1998) · PubMed · Cited by 61
Self-citationApte, R. S., Mayhew, E. S., & Niederkorn, J. Y. (1997) · PubMed · Cited by 60
(1991) · PubMed · Cited by 59
Self-citationWound-healing of corneal endothelium in monkey: an autoradiographic study.
Matsubara, M., & Tanishima, T. (1983) · PubMed · Cited by 58
Imposing deviant immunity on the presensitized state.
Kosiewicz, M. M., Okamoto, S., Miki, S., Ksander, B. R., Shimizu, T., & Streilein, J. W. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.7.2962 · Cited by 56
Self-citationHara, Y., Caspi, R. R., Wiggert, B. O., Dorf, M. E., & Streilein, J. W. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.5.1531 · Cited by 55
Self-citationCD4+ T CELLS ARE CRITICAL FOR CORNEAL, BUT NOT SKIN, ALLOGRAFT REJECTION1
Hašková, Z., Usiu, N., Pepose, J. S., Ferguson, T. A., & Stuart, P. M. (2000) · Transplantation · doi:10.1097/00007890-200002270-00004 · Cited by 55 · cited 1×
“This helps to explain why cytotoxic T cells have been found to have such a minor role in acute corneal allograft rejection in mice and rat”
BackgroundKezuka, T., & Streilein, J. W. (2000) · PubMed · Cited by 54
Self-citationSoluble Fas ligand and soluble Fas in ocular fluid of patients with uveitis
Sugita, S. (2000) · British Journal of Ophthalmology · doi:10.1136/bjo.84.10.1130 · Cited by 52
Ocular Immunosuppressive Microenvironment
Taylor, A. W. (1999) · KARGER eBooks · doi:10.1159/000058738 · Cited by 52
Immunobiology and Immunopathology of Corneal Transplantation
Streilein, J. W. (1999) · KARGER eBooks · doi:10.1159/000058746 · Cited by 52
Self-citationEXPRESSION OF A NONCLASSICAL MHC CLASS Ib MOLECULE IN THE EYE1
Niederkorn, J. Y., Chiang, E. Y., Ungchusri, T., & Stroynowski, I. (1999) · Transplantation · doi:10.1097/00007890-199912150-00025 · Cited by 51
Immune privilege persists in eyes with extreme inflammation induced by intravitreal LPS
Mo, J.-S., & Streilein, J. W. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200112)31:12<3806::aid-immu3806>3.0.co;2-m · Cited by 50
Self-citationSano, Y., Streilein, J. W., & Ksander, B. R. (1999) · Transplantation · doi:10.1097/00007890-199910150-00011 · Cited by 49
Self-citationNicholls, S. M., Bradley, B. B., & Easty, D. L. (1991) · PubMed · Cited by 45
Sano, Y., Okamoto, S., & Streilein, J. W. (1997) · Current Eye Research · doi:10.1076/ceyr.16.11.1171.5109 · Cited by 45
Self-citationWenkel, H., Chen, P., Ksander, B. R., & Streilein, J. W. (1999) · PubMed · Cited by 43
Self-citationYoshida, M., Kezuka, T., & Streilein, J. W. (2000) · PubMed · Cited by 42
Self-citationYamada, J., Ksander, B. R., & Streilein, J. W. (2001) · PubMed · Cited by 42
Self-citationRole of recipient epithelium in promoting survival of orthotopic corneal allografts in mice.
Hori, J., & Streilein, J. W. (2001) · PubMed · Cited by 41
Self-citationSano, Y., Br, K., & Jw, S. (2000) · PubMed · Cited by 39
Kezuka, T., & Streilein, J. W. (2000) · PubMed · Cited by 38
Self-citationGammadelta T cells in anterior chamber-induced tolerance in CD8(+) CTL responses.
Xu, Y., & Kapp, J. A. (2002) · PubMed · Cited by 38
Hori, J., & Streilein, J. W. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0399 · Cited by 33 · cited 1×
“First, conventional immune-recognition pathways can be interrupted by providing allografts with healthy corneal epithelium, or factors derived from this tissue that suppress lymphangiogenesis and attendant inflammatio”
BackgroundSelf-citationAnterior Chamber-Associated Immune Deviation
Niederkorn, J. Y. (1999) · KARGER eBooks · doi:10.1159/000058740 · Cited by 33
Ng, T. F., Osawa, H., Hori, J., Young, M. J., & Streilein, J. W. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5601 · Cited by 21
Self-citationγδ T Cells in Anterior Chamber-Induced Tolerance in CD8+ CTL Responses
Xu, Y., & Kapp, J. A. (2002) · Investigative Ophthalmology & Visual Science · Cited by 18
Non-Cleavable Mutant Fas Ligand Transfection of Donor Cornea Abrogates Ocular Immune Privilege
Sano, Y., Yamada, J., Ishino, Y., Adachi, W., Kawasaki, S., Suzuki, T., Kinoshita, S., Okuyama, T., & Azuma, N. (2002) · Experimental Eye Research · doi:10.1006/exer.2002.2044 · Cited by 16 · cited 1×
“Attempts to achieve this goal with CD95L have already been made and the results are mixe”
ResultAn Improved Method for Examining the Corneal Endothelium During Graft Rejection in the Rat
Figueiredo, F. C., Pendergrast, D., ZHANG, L., EASTY, D. L., & Nicholls, S. M. (1998) · Experimental Eye Research · doi:10.1006/exer.1998.0559 · Cited by 8 · cited 1×
“On the other hand, during the stress of immune rejection MHC class II molecules are highly expressed by corneal endothelial cells, making these corneal parenchymal cells potential targets for CD4 + effector T cell”
BackgroundAdequate HLA Matching in Keratoplasty
Sundmacher, R. (2002) · Developments in ophthalmology · doi:10.1159/isbn.978-3-318-00905-7 · Cited by 6
Research works printed but not linked: 5
- Haskova, Z., Arancibia-Carcamo, C. V., Christianson, G. J., Roopenian, D. C. & Ksander, B. R. in Uveitis in the Third Millenium (eds Dodds, E. M. & Couto, C. A.) 7–10 (Elsevier Science, Amsterdam, 2000).
- Sano, Y., Ksander, B. R. & Streilein, J. W. Fate of orthotopic corneal allografts in eyes that cannot support ACAID induction. Invest. Ophthalmol. Vis. Sci. 36, 2176–2185 (1995). This paper shows how immune privilege in the eye is disrupted by experimental manipulations of the cornea.
- Bora, H. S. et al. in Advances in Ocular Imunolology (eds Nussenblatt, R. B., Whitcup, S. M., Caspi, R. R. & Gery, I.) 83–86 (Amsterdam, Elsevier, 1994).
- Hori, J. & Streilein, J. W. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice. Invest. Ophthalmol. Vis. Sci. 42, 720–726 (2001).
- Ishida, K., Panjwani, N., Cao, Z. & Streilein, J. W. Participation of pigment epithelium in ocular immune privilege. 3. Galectin-1 contributes to immunosuppressive properties of retinal pigment epithelium. Ocular Immun. Inflamm. (in the press).
Cited by
The retina as a window to the brain—from eye research to CNS disorders
London, A., Benhar, I., & Schwartz, M. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.227 · Cited by 1,403
The Spleen in Local and Systemic Regulation of Immunity
Bronte, V., & Pittet, M. J. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.010 · Cited by 1,064
“Antigen inoculation in these immune privileged sites elicits a systemic immune response characterized by the induction of antigen-specific antibodies, failure tomount cellmediated immunity, and allograft acceptance (Streilein, 2003).”
BackgroundMechanisms of Age-Related Macular Degeneration
Ambati, J., & Fowler, B. J. (2012) · Neuron · doi:10.1016/j.neuron.2012.06.018 · Cited by 1,021
Hauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954
“In addition, the relative immune privilege of posterior ocular spaces is well appreciated (Streilein, 2003) and may serve to further limit any potential immune response to subretinal rAAV2 vector.”
Shechter, R., Miller, O., Yovel, G., Rosenzweig, N., London, A., Ruckh, J., Kim, K.-W., Klein, E., Kalchenko, V., Bendel, P., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.012 · Cited by 683
“The CP also expressed Vip and Thbs1, previously shown to promote immune deviation in immune-privileged sites (Figure 7F; Streilein, 2003).”
Metadata
- Authors
- Streilein, J. W.
- Affiliations
- Harvard University (US)
- Corresponding author
- Streilein, J. Wayne
- Venue
- Nature Reviews Immunology
- Published
- 2003-11
- Volume
- 3
- Issue
- 11
- Pages
- 879-889
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2166550261
- Cited by
- 807
- References
- 125
- Citations by year
- 2026: 33 · 2025: 33 · 2024: 40 · 2023: 31 · 2022: 43 · 2021: 54 · 2020: 46 · 2019: 31 · 2018: 33 · 2017: 44 · 2016: 39 · 2015: 34 · 2014: 28 · 2013: 31 · 2012: 37
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Keywords
- ocular immune privilege, eye, intraocular inflammation, vision loss, autoimmune eye disease, corneal transplantation, allograft acceptance, corneal immunology
- MeSH terms
- Animals, Autoimmune Diseases, Eye, Eye Diseases, Humans, Immunity, Inflammation, Transplantation, Homologous
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.